vanoxerine has been researched along with quipazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Göthert, M; Schlicker, E; Schunack, W | 1 |
| Hashim, A; Lajtha, A; Sershen, H | 1 |
2 other study(ies) available for vanoxerine and quipazine
| Article | Year |
|---|---|
Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs.
Topics: Animals; Desipramine; Dopamine; Electric Stimulation; Female; In Vitro Techniques; Male; Methylhistamines; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Histamine; Receptors, Histamine H3; Retina; Serotonin; Swine; Tritium | 1990 |
Serotonin-mediated striatal dopamine release involves the dopamine uptake site and the serotonin receptor.
Topics: Animals; Bicuculline; Cocaine; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; GABA Antagonists; Ketanserin; Male; Methiothepin; Mice; Mice, Inbred C57BL; Oxymetazoline; Piperazines; Quinoxalines; Quipazine; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2000 |